Intranasal naloxone compositions and methods of making and using same
US9289425B2 · kind B2 · utility
2Cited by
42References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2015 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Oct 14, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions containing an opioid antagonist such as naloxone and one or more pharmaceutically acceptable excipients. The compositions may be used for intranasal delivery of Naloxone for the treatment of, for example, opioid overdose in an individual in need thereof. Also disclosed are methods of making compositions containing Naloxone, and devices for nasal delivery of naloxone compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.